Interview on SGLT-2 Inhibitor Use (2): Prof. Watada Calls for Caution in Analyzing EPPV Data

March 9, 2015
Prof. Hirotaka Watada The Ministry of Health, Labor and Welfare (MHLW) has instructed drug makers to strengthen warnings in package inserts of sodium glucose co-transporter-2 (SGLT-2) inhibitors to heighten awareness of the risk of dehydration that can occur in patients...read more